Spinal stenosis is characterized by narrowing of the spaces within the spine which creates a pressure on the nerves travelling through the spine. It frequently occurs in the lower back and the neck. Lumbar and cervical stenosis are the two types of spinal stenosis and have various causes such as thickened ligaments and overgrowth of bone. The condition can be diagnosed by imaging tests such as X-ray and magnetic resonance imaging (MRI). It can be treated using medications, physical therapy, and surgical treatment such as laminectomy.
Request Brochure of Spinal Stenosis Market Report
Increase in the obese population suffering from spine deformities and rise in prevalence of spinal disorders such as degenerative scoliosis and degenerative spondylolisthesis among the geriatric population are projected to fuel the growth of the global spinal stenosis market during the forecast period. Furthermore, rise in popularity and adoption of minimally invasive spine surgery procedures and increase in the number of product offerings for the treatment of spinal stenosis are the other factors anticipated to propel the market.
The global spinal stenosis market can be segmented based on product, surgery type, end-user and region. In terms of product, the market can be bifurcated into thoracic fusion & lumbar fusion devices and cervical fusion devices. The thoracic fusion & lumbar fusion devices segment is projected to account for the largest market share during the forecast period due to rise in prevalence of lumber stenosis, increase in demand for lumber spinal fusion devices, and surge in the number of companies offering devices for the treatment of lumber spinal fusion.
Key players operating in the global spinal stenosis market are Medtronic, Alphatec Spine, Inc., DePuy Synthes, Stryker, Zimmer Biomet, NuVasive, Inc., Orthofix Holdings, Inc., Globus Medical Inc., K2M, Inc., and Vertiflex Inc.